$0.87
▲ +0.8% Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Cardiff Oncology Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing
Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital
Cardiff Oncology to Raise $10 Million in Share, Warrant Sale
Overview
52-week range
$1.35
$4.56
0% of range
Avg surprise (last 3)
-18.1%
Avg reaction (last 2)
+4.0%
100% positive
Latest IV / EM
76%
EM ±17.3% · $1 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.18 | $-0.13 | -38.5% | +10.0% | +2.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.17 | — | — | — | — | financials |
| Tue Jul 29, 2025 | Jun/2025 | $-0.21 | $-0.19 | -10.5% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.20 | $-0.19 | -5.3% | — | +5.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.25 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.26 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.22 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.22 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.25 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | -$0.17 | -$0.21 | +19.1% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-13M | — | $-12M | $-15M | $-14M | — | $-13M | $-13M |
| Net income | $-12M | — | $-11M | $-14M | $-13M | — | $-12M | $-12M |
| EPS (diluted) | $-0.18 | — | $-0.17 | $-0.21 | $-0.20 | — | $-0.25 | $-0.26 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $9M | $17M | $10M | $11M | $24M | $51M | $13M | $26M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $47M | $60M | $62M | $74M | $83M | $95M | $59M | $62M |
| Total assets | $49M | $62M | $64M | $76M | $85M | $97M | $63M | $66M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $14M | $16M | $15M | $17M | $14M | $14M | $14M | $14M |
| Total equity | $35M | $45M | $49M | $59M | $71M | $83M | $49M | $52M |